Skip to main content

Cancer Metabolism Focus Group

Join us for the inaugural Intercampus Cancer Metabolism Symposium, bringing together researchers from Cornell’s Ithaca and Weill Cornell Medicine campuses. The event will take place October 21–22, 2025, at Cornell Ithaca. 

register now

What is the Cancer Metabolism Focus Group?

The Cancer Metabolism Focus Group (CMFG) was started in 2023 by Dr. Praveen Sethupathay, Chair of the Department of Biomedical Sciences in the College of Veterinary Medicine.  CMFG is a collection of scientists from approximately 20 labs across Cornell-Ithaca who meet monthly to share and discuss the latest research in the area of cancer & metabolism.  The members of the CMFG executive committee are Anushka Dongre (Biomedical Sciences, committee chair), Meng Wang (Division of Nutritional Sciences), and Zeribe Nwosu (Molecular Biology and Genetics). Labs in the group represent at least four different colleges and eight different departments and is highly diverse and inclusive.  The idea for this center was borne out of the observation made in the Department of Biomedical Sciences that interest in cancer metabolism was steadily growing on campus during 2021-2023, with new hires in this area across several different departments and colleges. The vision for the CMFG was to create a space for these groups to come together, learn from each other, and forge collaborative connections. In particular, it was deemed that trainees should take the lead in presenting their own work or the latest cutting-edge published work in the field.

Murine breast tumor expressing E-cadherin (white), Vimentin (red) and DAPI (blue)
Murine breast tumor expressing E-cadherin (white), Vimentin (red) and DAPI (blue)
Image credit: Sophie Nelissen
Phase contrast image of murine quasi-mesenchymal breast cancer cells
Phase contrast image of murine quasi-mesenchymal breast cancer cells. 
Image credit: Shiney Chandraganti
CD4+ T-cells present in breast tumors. CD4+ T-cell (red) and DAPI (blue)
CD4+ T-cells present in breast tumors. CD4+ T-cell (red) and DAPI (blue). 
Image credit: Brian Feng